• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性萎缩性胃炎患者胃微生物群及代谢产物的变化

Changes of gastric microflora and metabolites in patients with chronic atrophic gastritis.

作者信息

Ma Yumei, Jiang Jianming, Yang Zhufeng, Li Yongzhang, Bai Haiyan, Liu Zongxiu, Zhang Shuo, Zhi Zheng, Yang Qian

机构信息

Department of Reserch Center, Hebei Province Hospital of Chinese Medicine, 389 Zhongshan East Road, Shijiazhuang, 050011, Hebei, China.

Hebei Key Laboratory of Integrated Chinese and Western Medicine for Gastroenterology Research, 389 Zhongshan East Road, Shijiazhuang, 050011, Hebei, China.

出版信息

J Transl Med. 2025 May 13;23(1):537. doi: 10.1186/s12967-025-06458-7.

DOI:10.1186/s12967-025-06458-7
PMID:40361215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12070603/
Abstract

BACKGROUND

Chronic atrophic gastritis (CAG) is related to the body's microbial and metabolic systems. Combined studies of microbiome and metabolomics can clarify the mechanisms of disease occurrence and progression. We used 16S rRNA sequencing, metagenomics sequencing and metabolomics sequencing to depict the landscapes of bacterium and metabolites, construct correlation networks of different bacterium and metabolites describe potential pathogenic mechanisms of chronic atrophic gastritis.

METHODS

The gastric juices of 30 non-atrophic gastritis (NAG) patients and 30 CAG patients were collected. Gastric microflora was analyzed by 16S rRNA sequencing and metagenomics sequencing. Gastric metabolites were analyzed by LC-MS analysis. Different bioinformatics methods were used to analyze the data of microbiome and metabolome, and to analyze the relationship between them.

RESULTS

In atrophic gastritis, bacteria diversity decreased. The genera with a mean decrease in Gini greater than 1.5 included peptostreptococcus, fusobacterium, prevotella, sphingomonas and bacteroides. KEGG pathway included renal cell carcinoma, proximal tubule bicarbonate reclamation, citrate cycle and aldosterone synthesis and secretion with significant enrichment of differential metabolites. Peptostreptococcus, fusobacterium, prevotella and sphingomonas were in pivot positions of the correlation network of differential metabolites and differential bacterium. Viral carcinogenesis, glycine serine and threonine metabolism, RNA polymerase, galactose metabolism and retinol metabolism were enriched in chronic atrophic gastritis based on the metagenomic sequencing data.

CONCLUSION

Peptostreptococcus, fusobacterium, prevotella, sphingomonas and bacteroides were the essential features that distinguish atrophic gastritis from non-atrophic gastritis, and caused disease by altering various metabolic pathways. Viral carcinogenesis, glycine serine and threonine metabolism, RNA polymerase, galactose metabolism and retinol metabolism may be related to the occurrence and progression of CAG.

摘要

背景

慢性萎缩性胃炎(CAG)与人体微生物和代谢系统相关。微生物组学和代谢组学的联合研究能够阐明疾病发生和发展的机制。我们运用16S rRNA测序、宏基因组测序和代谢组学测序来描绘细菌和代谢物图谱,构建不同细菌与代谢物的关联网络,以描述慢性萎缩性胃炎的潜在致病机制。

方法

收集30例非萎缩性胃炎(NAG)患者和30例CAG患者的胃液。通过16S rRNA测序和宏基因组测序分析胃微生物群。通过液相色谱 - 质谱分析(LC-MS分析)胃代谢物。采用不同的生物信息学方法分析微生物组和代谢组数据,并分析它们之间的关系。

结果

在萎缩性胃炎中,细菌多样性降低。基尼系数平均下降大于1.5的菌属包括消化链球菌属、梭杆菌属、普雷沃菌属、鞘氨醇单胞菌属和拟杆菌属。KEGG通路包括肾细胞癌、近端小管碳酸氢盐重吸收、柠檬酸循环以及醛固酮合成和分泌,差异代谢物有显著富集。消化链球菌属、梭杆菌属、普雷沃菌属和鞘氨醇单胞菌属处于差异代谢物与差异细菌关联网络的枢纽位置。基于宏基因组测序数据,病毒致癌、甘氨酸丝氨酸和苏氨酸代谢、RNA聚合酶、半乳糖代谢和视黄醇代谢在慢性萎缩性胃炎中富集。

结论

消化链球菌属、梭杆菌属、普雷沃菌属、鞘氨醇单胞菌属和拟杆菌属是区分萎缩性胃炎与非萎缩性胃炎的关键特征,并通过改变各种代谢途径引发疾病。病毒致癌、甘氨酸丝氨酸和苏氨酸代谢、RNA聚合酶、半乳糖代谢和视黄醇代谢可能与CAG 的发生和发展有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/f52c44841898/12967_2025_6458_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/6533e9a9686c/12967_2025_6458_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/0fcdb00d6a32/12967_2025_6458_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/6460084254d7/12967_2025_6458_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/f98a068e46a4/12967_2025_6458_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/d34ae89c8dd5/12967_2025_6458_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/f52c44841898/12967_2025_6458_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/6533e9a9686c/12967_2025_6458_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/0fcdb00d6a32/12967_2025_6458_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/6460084254d7/12967_2025_6458_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/f98a068e46a4/12967_2025_6458_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/d34ae89c8dd5/12967_2025_6458_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/12070603/f52c44841898/12967_2025_6458_Fig6_HTML.jpg

相似文献

1
Changes of gastric microflora and metabolites in patients with chronic atrophic gastritis.慢性萎缩性胃炎患者胃微生物群及代谢产物的变化
J Transl Med. 2025 May 13;23(1):537. doi: 10.1186/s12967-025-06458-7.
2
Dysregulated gastric microbial communities and functional shifts in chronic atrophic versus non-atrophic gastritis: a Helicobacter pylori-Negative observational study.慢性萎缩性胃炎与非萎缩性胃炎中胃微生物群落失调及功能变化:一项幽门螺杆菌阴性的观察性研究
BMC Gastroenterol. 2025 Apr 29;25(1):304. doi: 10.1186/s12876-025-03900-4.
3
Integrative metabolomics and microbiomics analysis reveals distinctive microbiota-metabolites interactions in gastric carcinogenesis.整合代谢组学和微生物组学分析揭示了胃癌发生过程中独特的微生物-代谢物相互作用。
Int J Cancer. 2025 Jun 15;156(12):2389-2400. doi: 10.1002/ijc.35392. Epub 2025 Mar 10.
4
Multi-omics analysis combined with network pharmacology revealed the mechanisms of rutaecarpine in chronic atrophic gastritis.多组学分析结合网络药理学揭示了吴茱萸碱治疗慢性萎缩性胃炎的机制。
J Ethnopharmacol. 2025 Jan 13;339:119151. doi: 10.1016/j.jep.2024.119151. Epub 2024 Nov 22.
5
Regulation of gut microbiota of Astragali Radix in treating for chronic atrophic gastritis rats based on metabolomics coupled with 16S rRNA gene sequencing.基于代谢组学结合 16S rRNA 基因测序技术研究黄芪调控慢性萎缩性胃炎大鼠肠道菌群的机制。
Chem Biol Interact. 2022 Sep 25;365:110063. doi: 10.1016/j.cbi.2022.110063. Epub 2022 Jul 21.
6
Xiaohuafuning tang intervenes liver-depression-and-spleen-deficiency syndrome chronic-atrophic-gastritis by reshaping amino acid metabolism through gut Microbiota.小花茯菟汤通过肠道微生物群重塑氨基酸代谢干预肝郁脾虚型慢性萎缩性胃炎。
Phytomedicine. 2025 Jan;136:156346. doi: 10.1016/j.phymed.2024.156346. Epub 2024 Dec 25.
7
GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.GADD45B 调控慢性萎缩性胃炎的癌变过程和胃癌的代谢途径。
Front Endocrinol (Lausanne). 2023 Aug 7;14:1224832. doi: 10.3389/fendo.2023.1224832. eCollection 2023.
8
Microbiota according to gastric topography in patients with low or high risk of gastric cancer in Nariño, Colombia.哥伦比亚纳里尼奥地区胃癌低风险或高风险患者胃不同部位的微生物群。
Biomedica. 2019 Aug 1;39(Supl. 2):157-171. doi: 10.7705/biomedica.v39i4.4520.
9
Integrating microbiome and metabolome revealed microbe-metabolism interactions in the stomach of patients with different severity of peptic ulcer disease.整合微生物组和代谢组揭示了不同严重程度消化性溃疡病患者胃中的微生物-代谢相互作用。
Front Immunol. 2023 Mar 9;14:1134369. doi: 10.3389/fimmu.2023.1134369. eCollection 2023.
10
Bile acid metabolism involved into the therapeutic action of Xiaojianzhong Tang via gut microbiota to treat chronic atrophic gastritis in rats.胆汁酸代谢通过肠道微生物群参与消癥建中汤治疗大鼠慢性萎缩性胃炎的治疗作用。
Phytomedicine. 2023 Jan;109:154557. doi: 10.1016/j.phymed.2022.154557. Epub 2022 Nov 18.

本文引用的文献

1
Chronic atrophic gastritis in different ages in South China: a 10-year retrospective analysis.中国南方不同年龄段慢性萎缩性胃炎的 10 年回顾性分析。
BMC Gastroenterol. 2023 Feb 9;23(1):37. doi: 10.1186/s12876-023-02662-1.
2
Prevalence of chronic atrophic gastritis worldwide from 2010 to 2020: an updated systematic review and meta-analysis.2010 年至 2020 年全球慢性萎缩性胃炎的患病率:一项更新的系统评价和荟萃分析。
Ann Palliat Med. 2022 Dec;11(12):3697-3703. doi: 10.21037/apm-21-1464.
3
Analysis of high risk factors for chronic atrophic gastritis.
分析慢性萎缩性胃炎的高危因素。
Saudi J Gastroenterol. 2023 Mar-Apr;29(2):127-134. doi: 10.4103/sjg.sjg_383_22.
4
Induction and Regulation of the Innate Immune Response in Helicobacter pylori Infection.幽门螺杆菌感染中固有免疫应答的诱导和调节。
Cell Mol Gastroenterol Hepatol. 2022;13(5):1347-1363. doi: 10.1016/j.jcmgh.2022.01.022. Epub 2022 Feb 3.
5
Estimating Dietary Intake from Grocery Shopping Data-A Comparative Validation of Relevant Indicators in Switzerland.从杂货店购物数据估计膳食摄入量——瑞士相关指标的比较验证。
Nutrients. 2021 Dec 29;14(1):159. doi: 10.3390/nu14010159.
6
Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis.网络药理学揭示摩罗丹治疗慢性萎缩性胃炎的作用机制。
Phytomedicine. 2022 Jan;95:153837. doi: 10.1016/j.phymed.2021.153837. Epub 2021 Nov 12.
7
Microbe-based management for colorectal cancer.基于微生物的结直肠癌管理。
Chin Med J (Engl). 2021 Dec 1;134(24):2922-2930. doi: 10.1097/CM9.0000000000001887.
8
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.美国胃肠病学会关于萎缩性胃炎诊断与管理的临床实践更新:专家综述
Gastroenterology. 2021 Oct;161(4):1325-1332.e7. doi: 10.1053/j.gastro.2021.06.078. Epub 2021 Aug 26.
9
Therapeutic effect of berberine on chronic atrophic gastritis based on plasma and urine metabolisms.小檗碱基于血浆和尿液代谢物治疗慢性萎缩性胃炎的疗效。
Eur J Pharmacol. 2021 Oct 5;908:174335. doi: 10.1016/j.ejphar.2021.174335. Epub 2021 Jul 12.
10
Microbe-based therapies for colorectal cancer: Advantages and limitations.基于微生物的结直肠癌治疗方法:优势与局限。
Semin Cancer Biol. 2022 Nov;86(Pt 3):652-665. doi: 10.1016/j.semcancer.2021.05.018. Epub 2021 May 18.